Tag:
Janssen Pharmaceutica
Latest Headlines
Latest Headlines
Janssen gets European green light for antipsychotic drug delivery
Janssen-Cilag International, a Johnson & Johnson company, has received approval from the European Commission for the first antipsychotic treatment for schizoaffective disorder. INVEGA
Janssen pays upper GI bill to Depomed for AcuForm tech
Janssen Pharmaceutica, a unit of Johnson & Johnson, has bought nonexclusive rights to use Depomed's AcuForm drug delivery technology for use in combination therapy. AcuForm contains "unique
